Enrollment for Metastatic Non-Small Cell Lung Cancer Trial Cleared by FDA
Lung Cancer, News
BeyondSpring Pharmaceuticals recently announced that the U.S. Food and Drug Administration (FDA) is allowing enrollment in the Phase 1/2 clinical trial to access the company’s drug plinabulin in combination with nivolumab for the treatment of metastatic ... Read more